✦ LIBER ✦

Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

✍ Scribed by P. Nielsen; R. Fischer; R. Engelhardt; P. Tondüry; E. E. Gabbe; G. E. Janka

Book ID: 114714340
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 632 KB
Volume: 91
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb05396.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Depletion of parenchymal and non-parench

Depletion of parenchymal and non-parenchymal iron stores in the ferrocene iron-loaded rat by treatment with deferiprone or deferoxamine

✍ P. Nielsen; R. Fischer; A. Braumann; J. Düllmann 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Exploring the “iron shuttle” hypothesis

Exploring the “iron shuttle” hypothesis in chelation therapy: Effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture

✍ Gabriela Link; Abraham M. Konijn; William Breuer; Z.Ioav Cabantchik; Chaim Hersh 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 152 KB

189 EFFECT OF IRON CHELATION THERAPY WIT

189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA

✍ Y. Deugnier; B. Turlin; M. Ropert-Bouchet; B. Rabault; P. Brissot 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Effect of deferiprone or deferoxamine on

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

✍ Gillian C Smith; Francisco Alpendurada; John Paul Carpenter; Mohammed H Alam; Va 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 590 KB

## Background Thalassaemia major (TM) patients need regular blood transfusions that lead to accumulation of iron and death from heart failure. Deferiprone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular (LV) function but little is

Safety issues of iron chelation therapy

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

✍ Kontoghiorghes, G J; Kolnagou, A; Peng, C-T; Shah, S V; Aessopos, A 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 201 KB

Successful chelation therapy with the co

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies

✍ Ersi Voskaridou; Dimitrios Christoulas; Evangelos Terpos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB